home / stock / armp / armp quote
Last: | $4.125 |
---|---|
Change Percent: | 0.61% |
Open: | $4.1 |
Close: | $4.10 |
High: | $4.14 |
Low: | $3.85 |
Volume: | 22,589 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.125 | $4.1 | $4.1 | $4.14 | $3.85 | 22,589 | 03-28-2024 |
$4.1 | $4.1 | $4.1 | $4.15 | $3.91 | 15,749 | 03-27-2024 |
$4.04 | $3.99 | $4.04 | $4.23 | $3.9256 | 14,039 | 03-26-2024 |
$3.91 | $3.6468 | $3.91 | $4.25 | $3.6468 | 57,335 | 03-25-2024 |
$3.74 | $3.72 | $3.74 | $3.78 | $3.48 | 6,274 | 03-22-2024 |
$3.69 | $3.78 | $3.69 | $3.9013 | $3.58 | 13,042 | 03-21-2024 |
$3.54 | $3.76 | $3.54 | $3.78 | $3.42 | 22,013 | 03-20-2024 |
$3.78 | $3.664 | $3.78 | $3.9 | $3.59 | 23,168 | 03-19-2024 |
$3.44 | $3.4 | $3.44 | $3.78 | $3.4 | 16,512 | 03-18-2024 |
$3.6 | $3.29 | $3.6 | $3.6 | $3.29 | 8,162 | 03-15-2024 |
$3.38 | $3.24 | $3.38 | $3.45 | $3.2 | 6,715 | 03-14-2024 |
$3.45 | $3.8 | $3.45 | $3.83 | $3.45 | 7,918 | 03-13-2024 |
$3.65 | $3.38 | $3.65 | $3.885 | $3.38 | 27,941 | 03-12-2024 |
$3.38 | $3.45 | $3.38 | $3.5 | $3.31 | 5,902 | 03-11-2024 |
$3.55 | $3.6 | $3.55 | $3.7 | $3.4518 | 7,902 | 03-08-2024 |
$3.55 | $3.65 | $3.55 | $3.775 | $3.47 | 6,672 | 03-07-2024 |
$3.71 | $3.97 | $3.71 | $3.97 | $3.66 | 3,854 | 03-06-2024 |
$3.77 | $4 | $3.77 | $4 | $3.7 | 17,542 | 03-05-2024 |
$4.12 | $4.06 | $4.12 | $4.48 | $4.01 | 36,555 | 03-04-2024 |
$4.07 | $4.0499 | $4.07 | $4.21 | $3.92 | 13,095 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Armata Pharmaceuticals Inc. Company Name:
ARMP Stock Symbol:
NYSE Market:
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , March 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology com...
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva PR Newswire Proceeds to be used to continue to advance rigorously designed clinical trials of Armata's high purity phage-based therapeutic candidates LOS ANGELES , March 4, 20...
Armata Pharmaceuticals Announces Presentation at the 6th Annual Bacteriophage Therapy Summit PR Newswire LOS ANGELES , Feb. 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on...